Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05100797
Other study ID # 2190/CEIH/2021
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 20, 2021
Est. completion date March 23, 2022

Study information

Verified date December 2021
Source Universidad de Granada
Contact Jonatan Ruiz Ruiz, Dr.
Phone 958242754
Email ruizj@ugr.es
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of the present study are described below: Aim 1: In-vitro measures to determine the validity, precision and accuracy of the Vyntus CPX metabolic cart assessed by: 1.1. Methanol burning tests. 1.2. Pure gas (nitrogen [N2] and carbon dioxide [CO2]) infusions to simulate both, constant and variable fluxes of oxygen consumption (VO2) and carbon dioxide production (VCO2) in different conditions and moments. 1. Immediately after or prior the methanol burning test (in a randomized order). 2. In separate days and time-periods. Aim 2: In-vivo measures using the Vyntus CPX metabolic cart: 2.1. To assess the resting metabolic rate (RMR or resting energy expenditure [REE]) and respiratory exchange ratio (RER) day-to-day biological reproducibility (i.e. reliability) of the metabolic cart. 2.2. Further, the investigators will use an oral glucose tolerance test (OGTT) to determine the post-prandial day-to-day biological reproducibility (especifically the post-prandial RER) of the metabolic cart.


Description:

The study will be developed in three different experiments which are detailed below: EXPERIMENT 1 (AIM 1.1 AND 1.2.A): The investigators will determine the Vyntus CPX measurement error over 14 different days by using both, methanol burnings and pure gas infusions. The order will be random. 1. Methanol burning: the investigators will burn the methanol inside the glass-cage and the investigators will measure dynamically the weight of burned alcohol; gas exchange will be continuously measured with the Vyntus CPX while the produced gases are directed into the metabolic cart's hose tube. The burning will take approximately 25-30 minutes and is expected to produce a RER=0.667. 2. Pure gas infusions: Pure N2 (concentration ≥99.9997%) for diluting ambient O2 and CO2 (concentration ≥99.995%) will be infused using high-precision mass-flow controllers (358 Series, Analyt-MTC, Müllheim, Germany; 0-2 l/min) into the metabolic cart's hose tube. The infused volumes of N2 and CO2 will be selected to replicate (i.e. mimic) as much as possible the VO2 and VCO2 produced by the methanol burning test. The gas infusions will last 20 minutes. EXPERIMENT 2 (AIM 1.2.B): The investigators will determine the Vyntus CPX measurement error over 14 different days by using pure gas infusions (each pure gas infusion will last 20 minutes). The procedures will be as follow: 1. Pure gas infusions varying, in a random order, the simulated VO2 and VCO2 to poduce different energy expenditure (EE) and RER values: the investigators will infuse pure N2 and CO2 gases at different volumes. The infusions will be performed either in the morning or in the afternoon (i.e. random) in 14 different and separate days. The randomly selected simulated EE will range between 1000 and 2000 kilocalories per day (kcal/day) while the RER will range between 0.80 and 0.95. The investigators will perform 5 pure gas infusions per day. 2. Pure gas infusions varying, in a random order, the simulated VO2 and VCO2 to produce different EE values while keeping a constant RER: the investigators will infuse pure N2 and CO2 gases at different volumes. The infusions will be performed either in the morning or in the afternoon (i.e. random) in 14 different and separate days. The randomly selected simulated EE will range between 1000 and 2000 kcal/day while the RER is fixed at 0.85. The investigators will perform 5 pure gas infusions per day. 3. Pure gas infusions varying, in a random order, the simulated VO2 and VCO2 to produce different RER values while keeping a constant EE: the investigators will infuse pure N2 and CO2 gases at different volumes. The infusions will be performed either in the morning or in the afternoon (i.e. random) in 14 different and separate days. The randomly selected simulated RER will range between 0.80 and 0.95 while the EE is fixed at 1500 kcal/day. The investigators will perform 5 pure gas infusions per day. EXPERIMENT 3 (AIM 2.1 and 2.2.): The investigators will assess the RMR and RER of 10-15 young-healthy adults using the Vyntus CPX metabolic cart on two consecutive days in the morning. The assessment will last 30 minutes and will be performed in agreement with current guidelines. The subjects will lay on a reclined bed in supine position and covered by a bed sheet for 20 minutes before the assessment as an 'acclimation period'. Immediately after this acclimation period the RMR and RER assessment will start under the same conditions. Then, the glucose beverage (75g of glucose/200ml) is given to the participants and another 180 minutes of assessment are performed. In addition, the participants' weight, height and body composition (using a dual X-ray absorptiometry scan [DXA scan]) will be measured upon arrival on the first visit. Blood samples will be collected at different time periods to determine the blood glucose concentration. Lastly, participants will be asked to consume a standardized dinner (specifically designed by a dietitians team) the night before each study day.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date March 23, 2022
Est. primary completion date February 23, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Healthy. - Age 18-40 y. - BMI between 18.5 kg/m2 and 30 kg/m2 (both inclusive). - Willing to fast and not to consume non-caloric stimulant for 12h before the assessments. - Willing to avoid moderate or vigorous physical activity during 24-48h respectively. - Have a stable body weight over the last 3 months (changes =3 kg) and not being enrolled in a weight loss program. Exclusion Criteria: - Smoking or use of tobacco products within the last 3 months. - Diagnosed with diabetes. - Previous bariatric surgery (or other surgeries) for obesity or weight loss. - Use of medications affecting metabolism or sleep. - History of neurological disease. - History of cardiovascular disease, including hypertension, or other chronic diseases. - Pregnant, planning to become pregnant, or breastfeeding. - Adherence to special restrained diets (e.g., low-carbohydrates, low-fat, or vegetarian/vegan diets) over the last 3 months. - Claustrophobia impeding to stay calm under a plastic canopy.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Vyntus CPX
To study the validity, precision and accuracy of the Vyntus CPX metabolic cart using both, in-vitro and in-vivo (i.e., human study) measures.

Locations

Country Name City State
Spain University of Granada Granada

Sponsors (1)

Lead Sponsor Collaborator
Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary VO2 post-prandial gas exchange assessed by indirect calorimetry Volume of oxygen consumption (VO2 [ml/min]) 5 hours
Primary VCO2 post-prandial gas exchange assessed by indirect calorimetry Volume of carbon dioxide production (VCO2 [ml/min]) 5 hours
Primary EE post-prandial gas exchange assessed by indirect calorimetry -Energy Expenditure (EE [kcal/day]) 5 hours
Primary RER post-prandial gas exchange assessed by indirect calorimetry Respiratory Exchange Ratio (RER [calculated as VCO2-to-VO2 ratio]) 5 hours
Primary CHOox post-prandial gas exchange assessed by indirect calorimetry Carbohydrate oxidation (CHOox [g/min]) 5 hours
Primary FATox post-prandial gas exchange assessed by indirect calorimetry Fat oxidation (FATox [g/min]) 5 hours
Primary VO2 validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. Volume of oxygen consumption (VO2) measurement error (ml/min) 14 separate days; measurements of 2 hours per day
Primary VCO2 validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. Volume of carbon dioxide production (VCO2) measurement error (ml/min) 14 separate days; measurements of 2 hours per day
Primary EE validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. Energy Expenditure (EE) measurement error (kcal/day) 14 separate days; measurements of 2 hours per day
Primary RER validity of the metabolic cart. In-vitro measurements and/or simulations to determine the validity, precision and accuracy of the metabolic cart assessed by methanol burning tests and controlled pure gas infusions. Respiratory Exchange Ratio (RER) measurement error 14 separate days; measurements of 2 hours per day
Secondary Post-prandial blood glucose concentrations Measures of blood glucose concentrations (mg/dl) 5 hours
Secondary Body composition outcomes (DXA scann) Lean mass, fat-free mass and fat mass in kilograms 1 day
Secondary Anthropometric measurements 1, weight Weight in kilograms 1 day
Secondary Anthropometric measurements 2, height Height in meters 1 day
Secondary Anthropometric measurements 3, body mass index BMI: Weight and height will be combined to report in kg/m^2 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A